Eversept Partners, LP Mannkind Corp Transaction History
Eversept Partners, LP
- $1.29 Billion
- Q3 2025
A detailed history of Eversept Partners, LP transactions in Mannkind Corp stock. As of the latest transaction made, Eversept Partners, LP holds 2,042,727 shares of MNKD stock, worth $10.3 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
2,042,727
Previous 697,710
192.78%
Holding current value
$10.3 Million
Previous $2.61 Million
320.43%
% of portfolio
0.85%
Previous 0.26%
Shares
9 transactions
Others Institutions Holding MNKD
# of Institutions
257Shares Held
165MCall Options Held
2.76MPut Options Held
689K-
Black Rock Inc. New York, NY22.6MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$89.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY11.4MShares$57.8 Million1.01% of portfolio
-
State Street Corp Boston, MA10.7MShares$54.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.39MShares$37.4 Million0.0% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.3B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...